medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 1

<< Back Next >>

Rev ADM 2026; 83 (1)

Biofilm and antibiotic resistance: evolution of knowledge, challenges, and development of new therapies.

Rosenda BM
Full text How to cite this article 10.35366/122574

DOI

DOI: 10.35366/122574
URL: https://dx.doi.org/10.35366/122574

Language: Spanish
References: 25
Page: 35-40
PDF size: 389.29 Kb.


Key words:

biofilm, therapies, resistance.

ABSTRACT

Introduction: oral biofilms represent a highly organized form of microbial life that contributes significantly to antimicrobial resistance. In the context of the oral cavity, these complex structures act as dynamic reservoirs of resistance and virulence genes. The capacity for genetic exchange within the biofilm poses clinical challenges, especially in chronic infections and in the colonization of medical devices by opportunistic oral microorganisms. Given the limited effectiveness of conventional antibiotics against these communities, the development of new therapeutic strategies becomes imperative. Therefore, the objective of this review is to explore the current state of knowledge on the topic. Material and methods: the search was conducted in the MEDLINE, PUBMED, SciELO, and LILACS databases, in English and/or Spanish, covering the period from 2015 to 2025. The searches were performed using the following DeCS/MeSH terms: biofilm, antibiotic resistance, genes, therapies. Results: the findings show the evolution of knowledge regarding biofilms and antibiotic resistance mechanisms, as well as new perspectives and emerging therapeutic strategies. Conclusion: a deep understanding of the biology and resistance mechanisms associated with biofilms is essential for designing more effective therapeutic strategies.


REFERENCES

  1. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28 (11): 1062-1068.

  2. Ehrlich GD, Arciola CR. From Koch's postulates to biofilm theory: the lesson of Bill Costerton. Int J Artif Organs. 2012; 35 (10): 695-699.

  3. Wright CJ, Burns LH, Jack AA, Back CR, Dutton LC, Nobbs AH et al. Microbial interactions in building of communities. Mol Oral Microbiol. 2013; 28 (2): 83-101.

  4. Escandón-Astudillo MA, Peña-Dután MG. Formación de biofilm y mecanismos de quorum sensing en resistencia antimicrobiana. Microbiol Clin. 2022; 39 (7): 567-580.

  5. Zerón A. Rebelión en el biofilm: una historia de hadas. Rev ADM. 2024; 81 (4): 197-200.

  6. Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018; 200 (4): 525-40.

  7. Lamont RJ, Bryers JD. Biofilm-induced gene expression and gene transfer. Methods Enzymol. 2001; 336: 84-94.

  8. Beserra PS. Estreptococos orales resistentes a la amoxicilina: adhesión, formación de biopelícula y susceptibilidad a antibióticos alternativos y clorhexidina [tesis]. 2025.

  9. López-Villalba N. Biofilm microbianas: su papel en la patogenicidad de infecciones y los desafíos terapéuticos en farmacia. 2025.

  10. Tapia AIT, Quezada APS, Rodríguez AER. Revisión crítica del impacto antibiótico en el ecosistema microbiano oral. Pro Sci Rev Prod Cienc Investig. 2025; 9 (58): 451-458.

  11. Komarovova PJC, et al. Aplicaciones y estudios de bacteriocinas. Rev Biotecnol Salud Aliment. 2024; 10 (2): 123-135.

  12. Zerón A. Papel del biofilm microbiano en la carcinogénesis. Rev Divulg Cient. 2024; 5 (1): 45-52.

  13. Sharma S, et al. Infecciones por biofilm y resistencia antimicrobiana. Int J Antimicrob Agents. 2023; 62 (3): 101-115.

  14. Cleaver L, Garnett JA. Avances tecnológicos en investigación de biofilm. Biofilm Res Rev. 2023; 15 (4): 200-215.

  15. Lopardo HA, Vigliarolo L, Bonofiglio L, Gagetti P, García-Gabarrot G, Kaufman S et al. Beta-lactam antibiotics and viridans group streptococci. Rev Argent Microbiol. 2022; 54 (4): 335-343.

  16. Alvarracin-Baculima M, Cuenca-León K, Pacheco-Quito EM. Nanopartículas antimicrobianas en odontología: estado del arte. 2021.

  17. Berardinelli EM, Lopardo HÁ. Patogenia y sensibilidad antibiótica en Streptococcus anginosus. Rev Odontol Latinoam. 2021; 25 (2): 75-85.

  18. Wille J, Coenye T. Dispersión de biofilm como estrategia terapéutica. Pathog Dis. 2020; 78 (5): ftaa036.

  19. González E, Zapata AC, Sánchez-Henao DF, Chávez-Vivas M. Resistencia a antibióticos β-lactámicos y eritromicina en bacterias de la cavidad oral. Nova. 2020; 18 (34): 27-45.

  20. Verderosa AD, Totsika M, Fairfull-Smith KE. Bacterial biofilm eradication agents: a current review. Front Chem. 2019; 7: 824.

  21. Loera-Muro A, Barraza A, Caamal-Chan MG. Diálogo entre bacterias. ¿Cómo se comunican las bacterias? Recursos Naturales y Sociedad. 2019; 5 (1): 24-39.

  22. Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018; 9 (1): 522-554.

  23. Larsen T, Fiehn NE. Biofilm dentales y enfermedades sistémicas. Periodontol 2000. 2017; 75 (1): 10-25.

  24. Trujillo GM. Biofilm microbianas como estrategia adaptativa. Rev Microbiol Aplicada. 2017; 44 (2): 55-67.

  25. Wu H, Moser C, Wang HZ, Hoiby N, Song ZJ. Strategies for combating bacterial biofilm infections. Int J Oral Sci. 2015; 7 (1): 1-7.




Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2026;83